Related references
Note: Only part of the references are listed.Recombinant BCGs for tuberculosis and bladder cancer
Alok K. Singh et al.
VACCINE (2021)
Human SLC46A2 Is the Dominant cGAMP Importer in Extracellular cGAMP-Sensing Macrophages and Monocytes
Anthony F. Cordova et al.
ACS CENTRAL SCIENCE (2021)
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar et al.
CANCERS (2021)
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Anne W. J. Martens et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Pathogenic E-coli Extracts Nutrients from Infected Host Cells Utilizing Injectisome Components
Ritesh Ranjan Pal et al.
CELL (2019)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
SLC19A1 Is an Importer of the Immunotransmitter cGAMP
Christopher Ritchie et al.
MOLECULAR CELL (2019)
Salmonella Pathogenicity Island 1 (SPI-1) and Its Complex Regulatory Network
Lixin Lou et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
SLC19A1 transports immunoreactive cyclic dinucleotides
Rutger D. Luteijn et al.
NATURE (2019)
Highly Efficient Preparation of Cyclic Dinucleotides via Engineering of Dinucleotide Cyclases in Escherichia coli
Yun Lv et al.
FRONTIERS IN MICROBIOLOGY (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells
Alice Gutjahr et al.
JCI INSIGHT (2019)
Structure of the Human cGAS-DNA Complex Reveals Enhanced Control of Immune Surveillance
Wen Zhou et al.
CELL (2018)
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
Ryszard Smolarczyk et al.
SCIENTIFIC REPORTS (2018)
Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose
Ping Zhou et al.
NATURE (2018)
Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
Valentin-Florian Rauca et al.
PLOS ONE (2018)
Invasive Salmonella exploits divergent immune evasion strategies in infected and bystander dendritic cell subsets
Anna Aulicino et al.
NATURE COMMUNICATIONS (2018)
Spotlight on protein N-terminal acetylation
Rasmus Ree et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Assembly, structure, function and regulation of type III secretion systems
Wanyin Deng et al.
NATURE REVIEWS MICROBIOLOGY (2017)
cGAS is activated by DNA in a length-dependent manner
Stefanie Luecke et al.
EMBO REPORTS (2017)
Salmonella SPI-2 Type III Secretion System Effectors: Molecular Mechanisms And Physiological Consequences
Elliott Jennings et al.
CELL HOST & MICROBE (2017)
The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation
Ethel Bayer-Santos et al.
CELL HOST & MICROBE (2016)
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
Emily Curran et al.
CELL REPORTS (2016)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Structure-Guided Reprogramming of Human cGAS Dinucleotide Linkage Specificity
Philip J. Kranzusch et al.
CELL (2014)
Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases
Annelies W. Mesman et al.
CELL HOST & MICROBE (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2′3′-cGAMP, Induces M2 Macrophage Repolarization
Charlene M. Downey et al.
PLOS ONE (2014)
Structure-Function Analysis of STING Activation by c[G(2′,5′) pA(3′,5′)p] and Targeting by Antiviral DMXAA
Pu Gao et al.
CELL (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING
Xu Zhang et al.
MOLECULAR CELL (2013)
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
Andrea Ablasser et al.
NATURE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING
Elie J. Diner et al.
CELL REPORTS (2013)
Structural Analysis of the STING Adaptor Protein Reveals a Hydrophobic Dimer Interface and Mode of Cyclic di-GMP Binding
Songying Ouyang et al.
IMMUNITY (2012)
Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors
Rita Figueira et al.
MICROBIOLOGY-SGM (2012)
Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
Shan Wan et al.
PLOS ONE (2012)
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Direct stimulation of T cells by type IIFN enhances the CD8+ T cell response during cross-priming
Agnes Le Bon et al.
JOURNAL OF IMMUNOLOGY (2006)
Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar typhimurium colitis in streptomycin-pretreated mice
S Hapfelmeier et al.
INFECTION AND IMMUNITY (2004)
Share Paper
